Family Medicine · American Fork, UT
NPI
1306952056
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
226 N 1100 E Ste A
American Fork, UT, 84003
Phone (801) 855-3848
Groups this clinician bills Medicare through
Medicare paid, 2024
$141K
6,177 services
Medicare patients, 2024
393
Average age 73
Drug cost, 2024
$978K
10,532 prescriptions
Company payments, 2025
$1,061
From 20 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mark K Hafen was code 99214 (office e&m - established), 734 times for 324 patients. In total Mark K Hafen billed 6,177 services in 142 codes, and Medicare paid $141K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-01-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 734 | 324 | $77.07 | $57K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 395 | 199 | $11.73 | $4,635 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 198 | 198 | $119.73 | $24K |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 186 | 186 | $17.14 | $3,188 |
| 99213 Office E&M - Established | Office | 162 | 123 | $54.45 | $8,821 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 123 | 24 | $0.69 | $84.37 |
| 83036 Blood Count | Office | 114 | 62 | $9.36 | $1,067 |
| J0696 Injection, ceftriaxone sodium, per 250 mg | Office | 91 | 12 | $0.34 | $30.65 |
| 96372 Injection Administration | Office | 82 | 31 | $9.03 | $740 |
| 81003 Clinical Chemistry | Office | 80 | 61 | $2.17 | $174 |
| 17003 Destruction Skin Lesion | Office | 61 | 11 | $4.60 | $280 |
| G0008 Administration of influenza virus vaccine | Office | 44 | 44 | $30.76 | $1,353 |
| 90662 Vaccine Product | Office | 36 | 36 | $80.72 | $2,906 |
| 87428 Infectious Agent Detection by DNA/RNA | Office | 33 | 31 | $62.25 | $2,054 |
| 91320 Vaccine Product | Office | 29 | 29 | $150.27 | $4,358 |
By year: 2022 $143K for 4,977 services; 2023 $147K for 4,568 services; 2024 $141K for 6,177 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 114 | 62 | $9.36 | $1,067 |
| 81003 Clinical Chemistry | 80 | 61 | $2.17 | $174 |
| 87428 Infectious Agent Detection by DNA/RNA | 33 | 31 | $62.25 | $2,054 |
| 87880 Immunoassay | 22 | 22 | $16.20 | $356 |
Medicare prescription drug claims, 2024
In 2024, the drug Mark K Hafen prescribed most often to Medicare patients was Atorvastatin Calcium, with 529 prescriptions and refills. In total Mark K Hafen wrote 10,532 Medicare prescriptions that cost $978K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 529 | 1,567 | 163 | $7,860 |
| Levothyroxine Sodium Generic | 498 | 1,333 | 137 | $5,822 |
| Lisinopril Generic | 334 | 949 | 106 | $3,261 |
| Omeprazole Generic | 259 | 741 | 82 | $5,913 |
| Zolpidem Tartrate Generic | 243 | 267 | 37 | $2,025 |
| Gabapentin Generic | 240 | 433 | 57 | $6,705 |
| Metformin Hcl Generic | 230 | 625 | 64 | $2,913 |
| Losartan Potassium Generic | 228 | 624 | 70 | $2,602 |
| Simvastatin Generic | 199 | 596 | 56 | $3,087 |
| Amlodipine Besylate Generic | 186 | 524 | 59 | $1,620 |
| Trazodone Hcl Generic | 167 | 336 | 45 | $1,377 |
| Tamsulosin Hcl Generic | 165 | 468 | 51 | $2,849 |
| Metformin Hcl Er Metformin Hcl | 148 | 393 | 41 | $1,603 |
| Rosuvastatin Calcium Generic | 146 | 430 | 48 | $2,029 |
| Mounjaro Tirzepatide | 131 | 136 | 21 | $145K |
Brand drugs: 1,194 claims; generic drugs: 9,287 claims; opioid claims: 379.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mark K Hafen $1,061 ($1,061 in general payments such as food, travel and fees) from 20 companies. The largest payer was Abbvie Inc. with $324.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 24 | $324 |
| Astellas Pharma US Inc 4503.T | 7 | $117 |
| Lundbeck LLC | 6 | $111 |
| Pfizer Inc. PFE | 3 | $64.07 |
| Tris Pharma Inc | 3 | $58.64 |
| AstraZeneca Pharmaceuticals LP AZN | 3 | $56.04 |
| Medtronic, Inc. MDT | 2 | $36.32 |
| Supernus Pharmaceuticals, Inc. SUPN | 2 | $33.07 |
| Novo Nordisk Inc NVO | 2 | $32.25 |
| GlaxoSmithKline, LLC. GSK | 2 | $28.56 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.